Cell Reports (Dec 2023)

IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis

  • Ana Valle-Noguera,
  • Lucía Sancho-Temiño,
  • Raquel Castillo-González,
  • Cristina Villa-Gómez,
  • María José Gomez-Sánchez,
  • Anne Ochoa-Ramos,
  • Patricia Yagüe-Fernández,
  • Blanca Soler Palacios,
  • Virginia Zorita,
  • Berta Raposo-Ponce,
  • José María González-Granado,
  • Julián Aragonés,
  • Aránzazu Cruz-Adalia

Journal volume & issue
Vol. 42, no. 12
p. 113508

Abstract

Read online

Summary: Group 3 innate lymphoid cells (ILC3s) are vital for defending tissue barriers from invading pathogens. Hypoxia influences the production of intestinal ILC3-derived cytokines by activating HIF. Yet, the mechanisms governing HIF-1α in ILC3s and other innate RORγt+ cells during in vivo infections are poorly understood. In our study, transgenic mice with specific Hif-1a gene inactivation in innate RORγt+ cells (RAG1KO HIF-1α▵Rorc) exhibit more severe colitis following Citrobacter rodentium infection, primarily due to the inability to upregulate IL-22. We find that HIF-1α▵Rorc mice have impaired IL-22 production in ILC3s, while non-ILC3 innate RORγt+ cells, also capable of producing IL-22, remain unaffected. Furthermore, we show that IL-18, induced by Toll-like receptor 2, selectively triggers IL-22 in ILC3s by transcriptionally upregulating HIF-1α, revealing an oxygen-independent regulatory pathway. Our results highlight that, during late-stage C. rodentium infection, IL-18 induction in the colon promotes IL-22 through HIF-1α in ILC3s, which is crucial for protection against this pathogen.

Keywords